Shilpa Medicare per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹15.28₹12.44₹8.04₹3.67₹3.74
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹15.28₹12.44₹8.04₹3.67₹3.74
₹132.47₹132.47₹242.58₹208.37₹205.44
₹86.02₹78.67₹131.55₹132.67₹120.98
—₹17.49₹13.52₹15.59₹26.06
−₹1.45−₹1.45−₹11.40−₹5.67−₹5.34
—₹0.50₹0.00₹0.00₹1.10
19.619.69.88.78.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHILPAMED₹935.60

Shilpa Medicare Ltd.

· Pharma & Health
₹ CrorePeersNATCOPHARMSPARCSTARRUBICONSUPRIYATHYROCAREVIYASHPARKHOSPSMcap ₹18,300 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS3.743.678.0412.4415.28
Diluted EPS3.743.678.0412.4415.28
Book Value per Share205.44208.37242.58132.47132.47
Revenue per Share120.98132.67131.5578.6786.02
Cash Flow per Share26.0615.5913.5217.49—
Free Cash Flow per Share-5.34-5.67-11.40-1.45-1.45
Dividends per Share1.100.000.000.50—
Shares Outstanding (cr)8.78.79.819.619.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.